Moderna, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG003PHHZT1
MRNA
Moderna, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Biotechnology
NAME
Moderna, Inc.
ISIN
US60770K1079
TICKER
MRNA
MIC
XNAS
REUTERS
MRNA.OQ
BLOOMBERG
MRNA US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 08.10.2024
Moderna
US60770K1079
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. (“Moderna” or “the Company”) (NASDAQ: MRNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors...
Moderna
Sun, 06.10.2024
Moderna
US60770K1079
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25, 2024. Moderna describes itself as a “biotechnology company that discovers, develops, and commercializes messenger RNA (“mRNA”) t...
Moderna
Sat, 24.08.2024
Moderna
US60770K1079
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc. (“Moderna” or “the Company”) (NASDAQ: MRNA) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violat...
Moderna
Mon, 19.08.2024
Moderna
US60770K1079
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25, 2024. Moderna describes itself as a “biotechnology company that discovers, develops, and commercializes messenger RNA (“mRNA”) therapeut...
Moderna
Sun, 18.08.2024
Moderna
US60770K1079
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Moderna, Inc. (NASDAQ: MRNA) securities between January 18, 2023 and June 25, 2024. Moderna is a biotechnology company that discovers, develops, and commercializes messenger RNA (“mRNA”) therapeutics and ...
Moderna
Fri, 16.08.2024
Moderna
US60770K1079
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc. (“Moderna” or “the Company”) (NASDAQ: MRNA) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violat...
Moderna
Thu, 15.08.2024
Moderna
US60770K1079
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Moderna, Inc. (NASDAQ: MRNA) securities between January 18, 2023 and June 25, 2024. Moderna is a biotechnology company that discovers, develops, and commercializes messenger RNA (“mRNA”) therapeutics and ...
Moderna
Sat, 10.08.2024
Moderna
US60770K1079
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. (“Moderna” or “the Company”) (NASDAQ: MRNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investor...
Moderna
Information on product placements
